ArticleDiscover mental health2026
Evaluation of alexithymia and clinical symptom severity in hospitalized Lebanese patients with schizophrenia.
Article in Discover mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAlexithymia, defined as difficulty identifying and describing one’s emotions, is highly prevalent in patients with schizophrenia and strongly correlates with negative, affective, and cognitive symptoms. The main objective was to examine the correlations between alexithymia and the severity of clinical symptoms among patients with schizophrenia.
methodsThe study included 101 inpatients diagnosed with schizophrenia according to DSM-5 criteria, recruited from the Psychiatric Hospital of the Cross in Lebanon. The Toronto Alexithymia Scale (TAS-20) was used to measure alexithymia. SPSS version 27 was used to conduct the statistical analysis for this study.
resultsThe results showed that 28.7% of subjects were alexithymic. The TAS‑20 total score was positively correlated with PANSS total score (r = 0.419, p < 0.001), as well as with positive symptoms (r = 0.331, p = 0.001), negative symptoms (r = 0.317, p = 0.001), and overall psychopathology symptoms (r = 0.361, p < 0.001). The results of regression analysis showed that the TAS-20 total score was associated with overall symptom severity (β = 1.06, 95% CI: 0.56–1.56, p < 0.001).
conclusionThis study demonstrated that alexithymia is significantly associated with the severity of schizophrenia symptoms in a stable inpatient population. These findings support the idea that alexithymia relates to the clinical expression of the disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.